Stock IIQ INOVIQ LTD
Add to a list
To use this feature you must be a member
Log inSign up

News INOVIQ Ltd

Equities

IIQ

AU0000196149

Delayed Australian S.E.
Other stock markets
 03:38:58 10/05/2024 BST 		5-day change 1st Jan Change
0.495 AUD 0.00% Intraday chart for INOVIQ Ltd +1.02% -25.56%
04-19 INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test MT
04-15 Fears of Middle East Conflict Escalation Quell Appetite for Australian Shares MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test
MT
Fears of Middle East Conflict Escalation Quell Appetite for Australian Shares
MT
INOVIQ Signs Supply, Distribution Agreement with Promega; Shares Surge 18%
MT
Inoviq's Test Detects 19% More Breast Cancers Than Market Leader
MT
INOVIQ Ltd Reports Earnings Results for the Half Year Ended December 31, 2023
CI
Inoviq Appoints Chair Elect; Shares Climb 13%
MT
Inoviq Signs Deal for Use of Biomarker Capture Product in the US
MT
INOVIQ Ltd Reports Earnings Results for the Full Year Ended June 30, 2023
CI
INOVIQ AND PROMEGA ANNOUNCE GLOBAL JOINT MARKETING AGREEMENT FOR EXO-NET EXOSOME ISOLATION AND NUCLEIC ACID PURIFICATION SOLUTIONS
AQ
INOVIQ Limited and Promega Corporation Announce Global Joint Marketing Agreement for EXO-NET Exosome Isolation and Nucleic Acid Purification Solutions
CI
Inoviq Signs Global Marketing Deal for Exosome Technology
MT
Inoviq Limited Announces Clinical Validation Study for Subb2m/Ca15-3 Breast Cancer Test
CI
Inoviq Confirms Efficacy of Breast Cancer Test
MT
INOVIQ Limited to Present New Exo-NET Data at ISEV Annual Meeting
CI
INOVIQ Ltd Reports Earnings Results for the Half Year Ended December 31, 2022
CI
INOVIQ Ltd Reports Earnings Results for the Half Year Ended December 31, 2022
CI
Inoviq's Breast Cancer Diagnostic Test Outdoes Commercial Test in Independent Study
MT
INOVIQ Limited Announces Positive Results for SubB2M Breast Cancer Test
CI
INOVIQ Ltd Announces Resignation of Professor Allan Cripps AO as Director
CI
INOVIQ's Ovarian Cancer Detection Kits Up to 90% Accurate, Study Says
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IIQ Stock
  4. News INOVIQ Ltd